Literature DB >> 19926262

Impact of psychotic features on morbidity and course of illness in patients with bipolar disorder.

I Ozyildirim1, S Cakir, O Yazici.   

Abstract

OBJECTIVE: In this study, we aimed to compare the clinical features and response patterns to the long-term prophylaxis of bipolar patients with or without psychotic features.
METHOD: The life charts of patients with bipolar I disorder were evaluated. Two hundred and eighty-one patients who suffer with bipolar disorder for at least 4 years and who had at least three mood episodes were included to the study. The patients whose all episodes are psychotic (psychotic group) and the patients who never experienced psychotic episode (non-psychotic group) were assigned as comparison groups. The clinical features and the response to long-term prophylaxis were compared across the groups.
RESULTS: The psychotic group consists of 43 patients; non-psychotic group consists of 54 patients. The history of bipolar disorder among the first-degree relatives was remarkably more prevalent in non-psychotic group (p=0.032). The predominance of manic/hypomanic episodes was significantly higher in psychotic group than non-psychotic group; and the rate of depressive episodes were higher in non-psychotic group than psychotic group (p=0.013). Episodes were more severe (p<0.001) and hospitalization rates were higher (p=0.023) in psychotic group. The response to lithium monotherapy was better in non-psychotic group (p<0.001).
CONCLUSION: The well identified psychotic subtype of bipolar patients may give important predictions about long term course and prophylaxis of bipolar disorder. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19926262     DOI: 10.1016/j.eurpsy.2009.08.004

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  9 in total

1.  Socio-demographic and clinical characterization of patients with Bipolar Disorder I vs II: a Nationwide Italian Study.

Authors:  A Carlo Altamura; Massimiliano Buoli; Bruno Cesana; Bernardo Dell'Osso; Gianluigi Tacchini; Umberto Albert; Andrea Fagiolini; Andrea de Bartolomeis; Giuseppe Maina; Emilio Sacchetti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-01       Impact factor: 5.270

2.  The effect of bariatric surgery on psychiatric course among patients with bipolar disorder.

Authors:  Ameena T Ahmed; E Margaret Warton; Catherine A Schaefer; Ling Shen; Roger S McIntyre
Journal:  Bipolar Disord       Date:  2013-08-05       Impact factor: 6.744

3.  Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder.

Authors:  Camila N C Lima; Robert Suchting; Giselli Scaini; Valeria A Cuellar; Alexandra Del Favero-Campbell; Consuelo Walss-Bass; Jair C Soares; Joao Quevedo; Gabriel R Fries
Journal:  Eur Neuropsychopharmacol       Date:  2022-07-08       Impact factor: 5.415

Review 4.  The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines.

Authors:  Konstantinos N Fountoulakis; Allan Young; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Pierre Blier; Hans Jurgen Moeller; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

Review 5.  Socio-demographic and clinical predictors of outcome to long-term treatment with lithium in bipolar disorders: a systematic review of the contemporary literature and recommendations from the ISBD/IGSLI Task Force on treatment with lithium.

Authors:  Diane Grillault Laroche; Bruno Etain; Emanuel Severus; Jan Scott; Frank Bellivier
Journal:  Int J Bipolar Disord       Date:  2020-12-16

6.  The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo-controlled, clinical trial.

Authors:  Rahim Badrfam; Seyed-Ali Mostafavi; Ali Khaleghi; Shahin Akhondzadeh; Atefeh Zandifar; Malihe Farid; Nami Mohammadian Khonsari; Mohammad Reza Mohammadi
Journal:  Brain Behav       Date:  2021-10-17       Impact factor: 2.708

Review 7.  Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors.

Authors:  Calogero Crapanzano; Ilaria Casolaro; Chiara Amendola; Stefano Damiani
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-08-31       Impact factor: 3.731

8.  Psychotic symptoms in bipolar disorder and their impact on the illness: A systematic review.

Authors:  Subho Chakrabarti; Navdeep Singh
Journal:  World J Psychiatry       Date:  2022-09-19

9.  Neurocognitive features in subgroups of bipolar disorder.

Authors:  Sofie Ragnhild Aminoff; Tone Hellvin; Trine Vik Lagerberg; Akiah Ottesen Berg; Ole A Andreassen; Ingrid Melle
Journal:  Bipolar Disord       Date:  2013-03-25       Impact factor: 6.744

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.